ABL Bio: Equity Investment of 22 Billion Won from Eli Lilly

1k Views14 Nov 2025 23:57

On 14 November, ABLBio (298380 KS) announced that it has signed an equity investment agreement with Eli Lilly & Co (LLY US) worth 22 billion won (US$15 million).

What is covered in the Full Insight:

Introduction to Investment Agreement
Details of Equity Investment
Technology Transfer Agreement
Company Background and Strategy
Financials and Shareholding Structure

Douglas Kim

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 5-minute read)

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream